Adarx Pharmaceuticals allocates 55% of IPO to 10 investors

By EC Assets · Published 25 September 2026

Adarx Pharmaceuticals Inc. allocated 55% of its initial public offering to 10 investors. The pharmaceutical company's IPO allocation details were published on September 25, 2026. This move signals a significant portion of the offering is directed towards a limited group. Adarx Pharmaceuticals Inc. uses the ticker ADRX. The company's balance sheet provides a summary of its financial condition. This includes its assets, liabilities, and other indicators. Investing.com published the news regarding Adarx Pharmaceuticals Inc.'s IPO. The information was provided by editor Vlad Schepkov. This news falls under stock market updates. This article is intended for informational purposes only. It does not constitute investment advice.